RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: toxic encephalopathy
Accession: DOID:3602
browse the term
Definition: A nervous system disease that results from exposure to neurotoxicants and is characterized by an altered mental status, memory loss, and visual problems. (DO)
Synonyms: exact_synonym: Neurotoxicity Syndrome; Neurotoxin Disease; Neurotoxin Diseases; Neurotoxin Disorder; Neurotoxin Disorders; nervous system poisoning; neurotoxic disorder; neurotoxic disorders; neurotoxicity syndromes; toxic encephalitides; toxic encephalitis; toxic encephalopathies
primary_id: MESH:D020258
alt_id: OMIA:001402
xref: EFO:0005595 ; NCI:C27961
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: 3435T>C(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12352921 PMID:17938643
RGD:11081146
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcg2
ATP binding cassette subfamily G member 2
susceptibility
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: :421C>A(human)
RGD
PMID:17938643
RGD:11081146
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Adcyap1
adenylate cyclase activating polypeptide 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29604313
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
G
Add3
adducin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adra1b
adrenoceptor alpha 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19125850
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21620937
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2l1
Bcl2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21972528
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
IEP
protein:decreased activity:serum:
RGD
PMID:16938375
RGD:9068882
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cck
cholecystokinin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Cd3d
CD3 delta subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21225912
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Drd2
dopamine receptor D2
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19576243
RGD:2311553
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
G
Egln1
egl-9 family hypoxia-inducible factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29471019
NCBI chr19:52,867,914...52,907,169
Ensembl chr19:52,869,486...52,907,777
G
Epha4
Eph receptor A4
IEP
RGD
PMID:10336070
RGD:5688752
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
G
Ephx1
epoxide hydrolase 1
susceptibility
ISO
DNA:missense mutation:cds:p.H139R (human)
RGD
PMID:17022435
RGD:5490249
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19220411
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gabrr2
gamma-aminobutyric acid type A receptor subunit rho 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 5:47,445,280...47,489,929
Ensembl chr 5:47,452,150...47,489,809
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:8923609 PMID:27220440
RGD:5490214 , RGD:14700956
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:17022435
RGD:5490249
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Igf1r
insulin-like growth factor 1 receptor
ISO
DNA: snp: intron: rs1879612: bortezomib induced
RGD
PMID:20864405
RGD:5686413
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
G
Il10
interleukin 10
treatment
IDA
RGD
PMID:23916895
RGD:7364985
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Lat
linker for activation of T cells
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
G
Mtor
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16955484
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20211941
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32014472
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20849151
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
P2rx1
purinergic receptor P2X 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr10:57,618,586...57,633,648
Ensembl chr10:57,618,586...57,633,623
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19442825
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21329748
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Prkcd
protein kinase C, delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22512859
NCBI chr16:5,769,226...5,807,214
Ensembl chr16:5,769,215...5,799,352
G
Ptges3
prostaglandin E synthase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29471019
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
G
Rnase6
ribonuclease A family member k6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr15:24,354,305...24,357,289
Ensembl chr15:24,354,303...24,357,328
G
Slc18a2
solute carrier family 18 member A2
IEP
protein:increased expression:thalamus (rat)
RGD
PMID:19798748
RGD:5130970
NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325
G
Srsf5
serine and arginine rich splicing factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
G
St8sia1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 4:175,782,989...175,921,338
Ensembl chr 4:175,789,947...175,920,708
G
Tgm1
transglutaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Timp3
TIMP metallopeptidase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 7:17,520,827...17,571,871
Ensembl chr 7:17,521,919...17,571,839
G
Cnr1
cannabinoid receptor 1
ISO
RGD
PMID:11841893
RGD:1626329
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:16318954
RGD:5688289
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
susceptibility
IEP
mRNA, protein:increased expression:inferior colliculus (rat)
RGD
PMID:25556199
RGD:152985539
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Slc29a1
solute carrier family 29 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283641
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:cortex, hippocampus (rat)
RGD
PMID:18585922
RGD:2313030
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Cirbp
cold inducible RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24223948
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Foxo4
forkhead box O4
IEP
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24972622
RGD:10401897
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:35,182,165...35,330,935
Ensembl chr12:35,182,154...35,330,987
G
Igf1
insulin-like growth factor 1
IEP
RGD
PMID:23016131
RGD:10402569
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP
RGD
PMID:23016131
RGD:10402569
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
IEP
RGD
PMID:23016131
RGD:10402569
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Akap9
A-kinase anchoring protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Alad
aminolevulinate dehydratase
IEP
protein:decreased activity:blood (rat)
RGD
PMID:19022878
RGD:4144202
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19805235
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
As3mt
arsenite methyltransferase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21447609 PMID:26366667 PMID:35226250
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
G
Atxn7
ataxin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr15:11,117,360...11,262,818
Ensembl chr15:11,118,886...11,263,106
G
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:68,466,469...68,467,941
Ensembl chr10:68,452,052...68,468,231
G
Ccrl2
C-C motif chemokine receptor like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd83
CD83 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
ISO
protein:increased expression:skin:
RGD
PMID:11860939
RGD:8662429
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22521605
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc3
ERCC excision repair 3, TFIIH core complex helicase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
G
Ercc4
ERCC excision repair 4, endonuclease catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Golga4
golgin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 8:118,208,200...118,285,003
G
Gsr
glutathione-disulfide reductase
IEP
RGD
PMID:25209654
RGD:10401880
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
G
Id2
inhibitor of DNA binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ier3
immediate early response 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr11:78,874,402...78,974,392
Ensembl chr11:78,874,414...78,974,377
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Inpp5a
inositol polyphosphate-5-phosphatase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25759212
NCBI chr 1:194,190,086...194,380,429
Ensembl chr 1:194,190,393...194,380,428
G
Kcnj2
potassium inwardly-rectifying channel, subfamily J, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:96,060,849...96,071,401
Ensembl chr10:96,060,821...96,071,445
G
Krt10
keratin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19953893
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr 2:211,530,598...211,546,858
Ensembl chr 2:211,530,602...211,546,821
G
Minpp1
multiple inositol-polyphosphate phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:230,354,483...230,379,730
Ensembl chr 1:230,354,438...230,379,730
G
Mir145
microRNA 145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29705342
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir155
microRNA 155
ISO
miRNA:increased expression:serum
RGD
PMID:27913196
RGD:25314296
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mt1
metallothionein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19953893
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24384392
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
N4bp2l2
NEDD4 binding protein 2-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr12:137,342...200,294
Ensembl chr12:103,590...197,784
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:243,408,659...243,413,701
Ensembl chr 1:243,408,619...243,413,817
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696
G
Peli1
pellino E3 ubiquitin protein ligase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
G
Pias1
protein inhibitor of activated STAT, 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
G
Pnp
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414634
NCBI chr15:24,170,456...24,178,274
Ensembl chr15:24,170,602...24,203,986
G
Ptx3
pentraxin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
G
Rfx3
regulatory factor X3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:225,449,872...225,709,622
Ensembl chr 1:225,456,187...225,709,402
G
Rgs1
regulator of G-protein signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr13:56,018,529...56,022,939
Ensembl chr13:56,018,554...56,022,984
G
Rnf20
ring finger protein 20
ISO
protein:increased expression:urine (human)
RGD
PMID:21136906
RGD:9831407
NCBI chr 5:63,976,063...64,001,754
Ensembl chr 5:63,976,045...64,001,754
G
Rufy3
RUN and FYVE domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr14:19,431,530...19,506,531
Ensembl chr14:19,432,524...19,507,004
G
Sfpq
splicing factor proline and glutamine rich
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Skil
SKI-like proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox18
SRY-box transcription factor 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:168,785,488...168,787,290
Ensembl chr 3:168,785,490...168,787,290
G
Srp68
signal recognition particle 68
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:101,481,213...101,508,035
Ensembl chr10:101,481,212...101,508,035
G
Ssbp1
single stranded DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnik
TRAF2 and NCK interacting kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:111,184,352...111,587,993
Ensembl chr 2:111,184,387...111,580,750
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18621066 PMID:19203779
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tra2a
transformer 2 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
G
Trappc10
trafficking protein particle complex subunit 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr20:10,438,737...10,499,074
Ensembl chr20:10,438,737...10,499,074
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr15:7,439,502...7,493,410
Ensembl chr15:7,439,759...7,493,400
G
Uso1
USO1 vesicle transport factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr14:15,866,638...15,932,185
Ensembl chr14:15,866,638...15,932,171
G
Usp13
ubiquitin specific peptidase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:115,576,912...115,689,153
Ensembl chr 2:115,577,091...115,686,222
G
Zfand6
zinc finger AN1-type containing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:138,581,002...138,652,052
Ensembl chr 1:138,581,002...138,651,939
G
Zfp267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:119,017,244...119,035,885
Ensembl chr 2:119,017,285...119,031,900
G
Abat
4-aminobutyrate aminotransferase
IMP
RGD
PMID:7740056 PMID:6445277
RGD:1598524 , RGD:10047091
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
IMP
RGD
PMID:18947822
RGD:6906919
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19109989
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cck
cholecystokinin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2320253
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Comt
catechol-O-methyltransferase
IMP
RGD
PMID:16437585
RGD:2289781
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
RGD
PMID:1673290
RGD:1358547
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Dbn1
drebrin 1
IEP
levodopainduced; protein:increased expression:striatum:
RGD
PMID:23241013
RGD:10398811
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Ddc
dopa decarboxylase
IEP
associated with Parkinson Disease; protein:decreased expression:striatum (rat)
RGD
PMID:20232137
RGD:5128860
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Drd1
dopamine receptor D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801
RGD:2311579
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20945430
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Egr1
early growth response 1
IEP
RGD
PMID:22153973
RGD:10395307
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17219962
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Gad1
glutamate decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9767399
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gch1
GTP cyclohydrolase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gdnf
glial cell derived neurotrophic factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11168568
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Glul
glutamate-ammonia ligase
IDA
RGD
PMID:6445277
RGD:10047091
NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Grk6
G protein-coupled receptor kinase 6
IMP
associated with Parkinson Disease
RGD
PMID:20410529
RGD:5684919
NCBI chr17:9,177,018...9,192,644
Ensembl chr17:9,177,019...9,192,644
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IMP
associated with Parkinsonian Disorders
RGD
PMID:26997328
RGD:13792768
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Homer1
homer scaffold protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24126708
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Htr1a
5-hydroxytryptamine receptor 1A
IMP
RGD
PMID:21352823
RGD:5683628
NCBI chr 2:36,694,174...36,695,442
Ensembl chr 2:36,694,174...36,695,442
G
Mapt
microtubule-associated protein tau
treatment
IDA
associated with Parkinsonian Disorders
RGD
PMID:25511986
RGD:13800920
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mtor
mechanistic target of rapamycin kinase
treatment
IMP
associated with Parkinsonian Disorders
RGD
PMID:23938307
RGD:10040953
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Pdyn
prodynorphin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9767399 PMID:21737418
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
IEP ISO
mRNA:increased expression:brain:striatum: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9767399 PMID:20456008
RGD:10003039
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
treatment
IDA
associated with Parkinsonian Disorders
RGD
PMID:27771532
RGD:13514053
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21115823
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rela
RELA proto-oncogene, NF-kB subunit
IEP
protein:increased expression:nucleus, brain
RGD
PMID:18590723
RGD:2298778
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rgs4
regulator of G-protein signaling 4
treatment
IMP
associated with Parkinsonian Disorders
RGD
PMID:24969021
RGD:13524515
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18160641 PMID:24663062
NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892
G
Th
tyrosine hydroxylase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
G
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 3:142,627,810...142,633,553
Ensembl chr 3:142,627,810...142,633,552
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
IMP IEP
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Igf1
insulin-like growth factor 1
IEP
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
G
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
G
Pten
phosphatase and tensin homolog
IEP
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838
G
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
G
Rhoa
ras homolog family member A
IEP
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Il16
interleukin 16
IEP
protein:increased expression:brain
RGD
PMID:14698845
RGD:1354526
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
G
Alad
aminolevulinate dehydratase
IEP
protein:decreased activity:striatum (rat)
RGD
PMID:18778733
RGD:4144152
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Atp13a2
ATPase cation transporting 13A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22285144
NCBI chr 5:153,292,722...153,312,143
Ensembl chr 5:153,292,751...153,312,139
G
Bnip3
BCL2 interacting protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19442826
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12171760
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Htt
huntingtin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19845833
NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Mfn2
mitofusin 2
IEP
protein:decreased expression:striatum (rat)
RGD
PMID:28232070
RGD:12910738
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15010209 PMID:22174044
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20089134
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Slc30a10
solute carrier family 30, member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28860195 PMID:29429640
NCBI chr13:96,998,143...97,048,076
Ensembl chr13:96,998,143...97,009,103
G
Slc31a1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22465424
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc39a14
solute carrier family 39 member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28860195
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc39a8
solute carrier family 39 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29429640
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23934647
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ctsb
cathepsin B
IMP
RGD
PMID:18638529
RGD:2315510
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15515958
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
S100b
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29566083
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31351185
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Ins2
insulin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26364587
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Alad
aminolevulinate dehydratase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21439310
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Ep300
E1A binding protein p300
IEP
mRNA:increased expression:hippocampus
RGD
PMID:24291742
RGD:9588309
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Slc6a1
solute carrier family 6 member 1
IEP
protein:increased expression:brain, synaptosome
RGD
PMID:15149801
RGD:1643208
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
ISO
associated with schizophrenia
RGD
PMID:10889552
RGD:1358545
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Drd3
dopamine receptor D3
ISO
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Sod2
superoxide dismutase 2
ISO
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all